Clinical Trial Update: Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of eRapa for Familial Adenomatous Polyposis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• ERapa

Snippet

Sponsor: Rapamycin Holdings Inc. | Conditions: Familial Adenomatous Polyposis (FAP) | Phase 3 | Status: RECRUITING